4/7/2017 the 52week High was .30/share. My guess without some more interesting news could go to .05-.09 given the 3/6/18 Gardner Insights report showing them as a major player in prostate immunization drug development. The More key investors gradually pick the this information up that level not unreasonable but that’s my best cloudy crystal ball guess.
News 
Market Data 
Discover 
